Immunogenicity of a psoralen-inactivated dengue virus type 1 vaccine candidate in mice

Clinical and Vaccine Immunology

Volumn 17, Issue 2, 2010, Pages 304-306

  Maves, Ryan C ^a   Castillo Oré, Roger M ^a   Porter, Kevin R ^b   Kochel, Tadeusz J ^a  

^a California   (Peru)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; DENGUE VACCINE; INACTIVATED VIRUS VACCINE; NEUTRALIZING ANTIBODY; PSORALEN;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 75749135300     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00353-09     Document Type: Article

References (12)

1. Allain, J. P., J. Hsu, M. Pranmeth, D. Hanson, A. Stassinopoulos, L. Fischetti, L. Corash, and L. Lin. 2006. Quantification of viral inactivation by photochemical treatment with amotosalen and UV A light, using a novel polymerase chain reaction inhibition method with preamplification. J. Infect. Dis. 194:1737-1744.
2. Brown, F. 1991. An overview of the inactivation of FMDV and the implications when residual virus is present in vaccines. Dev. Biol. Stand. 75:37-41.
3. Brown, F. 1993. Review of accidents caused by incomplete inactivation of viruses. Dev. Biol. Stand. 81:103-107.
4. Groene, W. S., and R. D. Shaw. 1992. Psoralen preparation of antigenically intact noninfectious rotavirus particles. J. Virol. Methods 38:93-102.
5. Hanson, C. V., J. L. Riggs, and E. H. Lennette. 1978. Photochemical inactivation of DNA and RNA viruses by psoralen derivatives. J. Gen. Virol. 40:345-358.
6. Hearst, J. E. 1981. Psoralen photochemistry and nucleic acid structure. J. Invest. Dermatol. 77:39-44.
7. Lin, L., D. N. Cook, G. P. Wiesehahn, R. Alfonso, B. Behrman, G. D. Cimino, L. Corten, P. B. Damonte, R. Dikeman, K. Dupuis, Y. M. Fang, C. V. Hanson, J. E. Hearst, C. Y. Lin, H. F. Londe, K. Metchette, A. T. Nerio, J. T. Pu, A. A. Reames, M. Rheinschmidt, J. Tessman, S. T. Isaacs, S. Wollowitz, and L. Corash. 1997. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 37:423-435.
8. Moghaddam, A., W. Olszewska, B. Wang, J. S. Tregoning, R. Helson, Q. J. Sattentau, and P. J. Openshaw. 2006. A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines. Nat. Med. 12:905-907.
9. Morens, D. M., S. B. Halstead, P. M. Repik, R. Putvatana, and N. Raybourne. 1985. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J. Clin. Microbiol. 22:250-254.
10. National Research Council, Institute of Laboratory Animal Resources. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
11. Roback, J. D., M. Conlan, W. L. Drew, P. Ljungman, W. G. Nichols, and J. K. Preiksaitis. 2006. The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections. Transfus. Med. Rev. 20:45-56.
12. Singh, Y., L. S. Sawyer, L. S. Pinkoski, K. W. Dupuis, J. C. Hsu, L. Lin, and L. Corash. 2006. Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion 46:1168-1177.